NCT07636824
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
- Locations
-
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,027 public trials
1,169 recruiting studies
Adenocarcinoma trial results
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
NCT06118086
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
- Locations
-
- University of California San Francisco Helen Diller Comprehensive Cancer Center San Francisco, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Dana Farber Cancer Research Institute Boston, Massachusetts, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
Recruiting
A Study of PHST001 in Advanced Solid Tumors
NCT06840886
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +27 more
- Locations
-
- Precision NextGen Oncology & Research Center Beverly Hills, California, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- Stanford University School of Medicine Palo Alto, California, United States
- Sarah Cannon Research Institute (SCRI) Oncology Partners - Denver Health One Denver, Colorado, United States
NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT04114136
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +28 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT07636252
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +16 more
- Locations
-
- Sheba Medical Center Ramat Gan, Israel
Recruiting
Using Tumor Models to Determine Treatments
NCT06813079
- Conditions
- Adenocarcinoma, Advanced Cancer, Carcinoma, +15 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Recruiting
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
NCT07432633
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
NCT07387198
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
- Locations
-
- Nationales Centrum für Tumorerkrankungen Heidelberg, Baden-Wurttemberg, Germany
- Universitätsklinikum Mannheim Mannheim, Baden-Wurttemberg, Germany
- Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
- Universitätsklinikum Regensburg Regensburg, Bavaria, Germany
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
NCT05176483
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
- Locations
-
- Exelixis Clinical Site #67 Phoenix, Arizona, United States
- Exelixis Clinical Site #1 Tucson, Arizona, United States
- Exelixis Clinical Site #123 Palo Alto, California, United States
- Exelixis Clinical Site #59 Santa Barbara, California, United States